検索結果 - Allen C. Gao

結果の絞り込み
  1. 1
    Molecular mechanisms of castration-resistant prostate cancer progression

    Molecular mechanisms of castration-resistant prostate cancer progression 著者: Smitha Dutt, Allen C. Gao

    出版事項 2009
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  2. 2
    Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells

    Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells 著者: Ramakumar Tummala, Wei Lou, Allen C. Gao, Nagalakshmi Nadiminty

    出版事項 2017
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    Targeting molecular resistance in castration-resistant prostate cancer

    Targeting molecular resistance in castration-resistant prostate cancer 著者: Thenappan Chandrasekar, Joy C. Yang, Allen C. Gao, Christopher P. Evans

    出版事項 2015
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  4. 4
    Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer

    Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer 著者: Chengfei Liu, Cameron M. Armstrong, Yezi Zhu, Wei Lou, Allen C. Gao

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Antiandrogens Inhibit ABCB1 Efflux and ATPase Activity and Reverse Docetaxel Resistance in Advanced Prostate Cancer

    Antiandrogens Inhibit ABCB1 Efflux and ATPase Activity and Reverse Docetaxel Resistance in Advanced Prostate Cancer 著者: Yezi Zhu, Chengfei Liu, Cameron M. Armstrong, Wei Lou, Amandeep Sandher, Allen C. Gao

    出版事項 2015
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer

    NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer 著者: Nagalakshmi Nadiminty, Ramakumar Tummala, Chengfei Liu, Wei Lou, Christopher P. Evans, Allen C. Gao

    出版事項 2015
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells

    Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells 著者: Chengfei Liu, Yezi Zhu, Wei Lou, YuanYuan Cui, Christopher P. Evans, Allen C. Gao

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Stat3 activation of NF-κB p100 processing involves CBP/p300-mediated acetylation

    Stat3 activation of NF-κB p100 processing involves CBP/p300-mediated acetylation 著者: Nagalakshmi Nadiminty, Wei Lou, Soo Ok Lee, Xin Lin, Donald L. Trump, Allen C. Gao

    出版事項 2006
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    Prostate Specific Antigen Expression Is Down-Regulated by Selenium through Disruption of Androgen Receptor Signaling

    Prostate Specific Antigen Expression Is Down-Regulated by Selenium through Disruption of Androgen Receptor Signaling 著者: Yan Dong, Soo Ok Lee, Haitao Zhang, James R. Marshall, Allen C. Gao, Clement Ip

    出版事項 2004
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition

    Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition 著者: Chengfei Liu, Wei Lou, Cameron M. Armstrong, Yezi Zhu, Christopher P. Evans, Allen C. Gao

    出版事項 2015
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  11. 11
    Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer

    Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer 著者: Chengfei Liu, Wei Lou, Yezi Zhu, Nagalakshmi Nadiminty, Chad Schwartz, Christopher P. Evans, Allen C. Gao

    出版事項 2014
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    Inhibition of ABCB1 Expression Overcomes Acquired Docetaxel Resistance in Prostate Cancer

    Inhibition of ABCB1 Expression Overcomes Acquired Docetaxel Resistance in Prostate Cancer 著者: Yezi Zhu, Chengfei Liu, Nagalakshmi Nadiminty, Wei Lou, Ramakumar Tummala, Christopher P. Evans, Allen C. Gao

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  13. 13
    Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2

    Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2 著者: Siting Feng, Qi‐Zhu Tang, Meng Sun, Jae Yeon Chun, Christopher P. Evans, Allen C. Gao

    出版事項 2009
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  14. 14
    Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer

    Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer 著者: Chengfei Liu, Cameron M. Armstrong, Wei Lou, Alan P. Lombard, Christopher P. Evans, Allen C. Gao

    出版事項 2016
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants

    NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants 著者: Nagalakshmi Nadiminty, Ramakumar Tummala, Chengfei Liu, Joy C. Yang, Wei Lou, Christopher P. Evans, Allen C. Gao

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy

    The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy 著者: Elisabeth A. Messner, Thomas M. Steele, Maria Malvina Tsamouri, Nazila Hejazi, Allen C. Gao, Maria Mudryj, P. Ghosh

    出版事項 2020
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  17. 17
    Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer

    Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer 著者: Chengfei Liu, Wei Lou, Yezi Zhu, Joy C. Yang, Nagalakshmi Nadiminty, Nilesh W. Gaikwad, Christopher P. Evans, Allen C. Gao

    出版事項 2015
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  18. 18
    ABCB1 Mediates Cabazitaxel–Docetaxel Cross-Resistance in Advanced Prostate Cancer

    ABCB1 Mediates Cabazitaxel–Docetaxel Cross-Resistance in Advanced Prostate Cancer 著者: Alan P. Lombard, Chengfei Liu, Cameron M. Armstrong, Vito Cucchiara, Xinwei Gu, Wei Lou, Christopher P. Evans, Allen C. Gao

    出版事項 2017
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    Inhibition of Galectin-1 and Androgen Receptor Axis Enhances Enzalutamide Treatment in Enzalutamide Resistant Prostate Cancer

    Inhibition of Galectin-1 and Androgen Receptor Axis Enhances Enzalutamide Treatment in Enzalutamide Resistant Prostate Cancer 著者: Hsiao-Chi Wang, Allen C. Gao, Roger Xia, Chun‐Te Wu, Ssu-Wei Hsu, Ching‐Hsien Chen, Tsung‐Chieh Shih

    出版事項 2025
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    Aberrant Activation of the Androgen Receptor by NF-κB2/p52 in Prostate Cancer Cells

    Aberrant Activation of the Androgen Receptor by NF-κB2/p52 in Prostate Cancer Cells 著者: Nagalakshmi Nadiminty, Wei Lou, Meng Sun, Jun Chen, Yue Jiao, Hsing-Jien Kung, Christopher P. Evans, Qinghua Zhou, Allen C. Gao

    出版事項 2010
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: